CTOs on the Move

Subtle Medical

www.subtlemedical.com

 
Subtle, Inc., is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Subtle Medical raised $12.2M on 11/20/2020

Similar Companies

Aspen Seating

Aspen Seating is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith and Nephew is a Andover, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sun Dental Labs

Sun Dental Labs is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Cable Specialist

Medical Cable Specialist is a Fletcher, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.